RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer

Haiyan Yang1,2, Jiong Hu1,2, Jingde Chen3

  • 1Department of Medical Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Insights

Musashi 2 (MSI2) promotes pancreatic cancer progression by suppressing SAV1 and MOB1. This oncoprotein disrupts the Hippo signaling pathway at a post-transcriptional level, driving tumor growth and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Musashi 2 (MSI2) is implicated as an oncoprotein in pancreatic ductal adenocarcinoma (PDAC).
  • The precise mechanisms by which MSI2 drives PDAC development and progression remain incompletely understood.
  • Understanding MSI2's role is crucial for developing targeted therapies for PDAC.

Purpose of the Study:

  • To investigate the clinical significance of MSI2 in PDAC.
  • To elucidate the biological effects of MSI2 on PDAC cell behavior.
  • To uncover the underlying molecular mechanisms of MSI2 in PDAC progression, focusing on the Hippo signaling pathway.

Main Methods:

  • Immunohistochemical analysis of MSI2, MOB1, and SAV1 expression in PDAC tissues.
  • Gain- and loss-of-function assays to assess MSI2's impact on PDAC cell proliferation, migration, and invasion.
  • Molecular biology techniques to investigate MSI2's regulation of the Hippo signaling pathway via SAV1 and MOB1.

Main Results:

  • MSI2 expression is significantly elevated in PDAC cell lines and tissues.
  • Increased MSI2 correlates with poorer tumor differentiation, lymph node metastasis, and advanced TNM stages.
  • MSI2 overexpression enhances PDAC cell proliferation, migration, and invasion.

Conclusions:

  • MSI2 directly binds to SAV1 and MOB1 mRNAs, suppressing their translation and stability at the post-transcriptional level.
  • MSI2 dysregulates the Hippo signaling pathway by inhibiting SAV1 and MOB1, thereby promoting PDAC progression.
  • Targeting MSI2 may offer a therapeutic strategy for pancreatic cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K